Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C31H32N4O2 |
| Molecular Weight | 492.6114 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)N1C(=O)N(C2CCN(CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)CC2)C5=C1C=CC=C5
InChI
InChIKey=FLKWNFFCSSJANB-UHFFFAOYSA-N
InChI=1S/C31H32N4O2/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25/h3-16,26H,2,17-22H2,1H3
| Molecular Formula | C31H32N4O2 |
| Molecular Weight | 492.6114 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4913411 |
Primary | Burgodin Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The use of driving impairing medicines: a European survey. | 2009-11 |
|
| Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. | 2003-11 |
|
| Bezitramide, an orally active analgesic. An investigation on pain following operations for lumbar disc protrusion (preliminary report). | 1970-04 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6519169
5 mg
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:08:49 GMT 2025
by
admin
on
Wed Apr 02 07:08:49 GMT 2025
|
| Record UNII |
3KXW0Y310I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
||
|
WHO-VATC |
QN02AC05
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
||
|
WHO-ATC |
N02AC05
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
||
|
DEA NO. |
9800
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2104149
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
DB01459
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
m2470
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | Merck Index | ||
|
239-335-4
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
BEZITRAMIDE
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
3KXW0Y310I
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
C72109
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
100000085875
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
DTXSID90165197
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
15301-48-1
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
1942
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
363
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
SUB05811MIG
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY | |||
|
61791
Created by
admin on Wed Apr 02 07:08:49 GMT 2025 , Edited by admin on Wed Apr 02 07:08:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
METABOLITE ACTIVE -> PRODRUG |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |